Mitochondrial Sirtuin 3 and Renal Diseases

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Mitochondria are dynamic organelles whose functions are tightly regulated at multiple levels to maintain proper cellular homeostasis. Mitochondrial Sirtuin 3 (SIRT3), which belongs to an evolutionary conserved family of NAD+-dependent deacetylases, is a key regulator of the mitochondrial respiratory chain, ATP production, and fatty acid β-oxidation, and it exerts an antioxidant activity. Changes in SIRT3 expression are critical in the pathophysiology of several diseases, such as metabolic syndrome, diabetes, cancer, and aging. In experimental acute kidney injury (AKI), impairment of renal function and development of tubular injury are associated with SIRT3 reduction and mitochondrial dysfunction in proximal tubuli. SIRT3-deficient mice are more susceptible to AKI and die. Pharmacological manipulations able to increase SIRT3 preserve mitochondrial integrity, markedly limit renal injury, and accelerate functional recovery. This review highlights all the selective rescue mechanisms that point to the key role of SIRT3 as a new therapeutic target for curing renal diseases.

Original languageEnglish
JournalNephron
DOIs
Publication statusAccepted/In press - Jul 1 2016

Fingerprint

Sirtuin 3
Kidney
Acute Kidney Injury
Wounds and Injuries
Electron Transport
Organelles
NAD
Mitochondria
Homeostasis
Fatty Acids
Antioxidants
Adenosine Triphosphate
Pharmacology

Keywords

  • Mitochondria
  • Renal diseases
  • Sirtuin 3

ASJC Scopus subject areas

  • Physiology
  • Nephrology
  • Urology
  • Physiology (medical)

Cite this

Mitochondrial Sirtuin 3 and Renal Diseases. / Perico, Luca; Morigi, Marina; Benigni, Ariela.

In: Nephron, 01.07.2016.

Research output: Contribution to journalArticle

@article{de8a12f23e2648ff8fce284a4dafdee0,
title = "Mitochondrial Sirtuin 3 and Renal Diseases",
abstract = "Mitochondria are dynamic organelles whose functions are tightly regulated at multiple levels to maintain proper cellular homeostasis. Mitochondrial Sirtuin 3 (SIRT3), which belongs to an evolutionary conserved family of NAD+-dependent deacetylases, is a key regulator of the mitochondrial respiratory chain, ATP production, and fatty acid β-oxidation, and it exerts an antioxidant activity. Changes in SIRT3 expression are critical in the pathophysiology of several diseases, such as metabolic syndrome, diabetes, cancer, and aging. In experimental acute kidney injury (AKI), impairment of renal function and development of tubular injury are associated with SIRT3 reduction and mitochondrial dysfunction in proximal tubuli. SIRT3-deficient mice are more susceptible to AKI and die. Pharmacological manipulations able to increase SIRT3 preserve mitochondrial integrity, markedly limit renal injury, and accelerate functional recovery. This review highlights all the selective rescue mechanisms that point to the key role of SIRT3 as a new therapeutic target for curing renal diseases.",
keywords = "Mitochondria, Renal diseases, Sirtuin 3",
author = "Luca Perico and Marina Morigi and Ariela Benigni",
year = "2016",
month = "7",
day = "1",
doi = "10.1159/000444370",
language = "English",
journal = "Experimental Nephrology",
issn = "0028-2766",
publisher = "S. Karger AG",

}

TY - JOUR

T1 - Mitochondrial Sirtuin 3 and Renal Diseases

AU - Perico, Luca

AU - Morigi, Marina

AU - Benigni, Ariela

PY - 2016/7/1

Y1 - 2016/7/1

N2 - Mitochondria are dynamic organelles whose functions are tightly regulated at multiple levels to maintain proper cellular homeostasis. Mitochondrial Sirtuin 3 (SIRT3), which belongs to an evolutionary conserved family of NAD+-dependent deacetylases, is a key regulator of the mitochondrial respiratory chain, ATP production, and fatty acid β-oxidation, and it exerts an antioxidant activity. Changes in SIRT3 expression are critical in the pathophysiology of several diseases, such as metabolic syndrome, diabetes, cancer, and aging. In experimental acute kidney injury (AKI), impairment of renal function and development of tubular injury are associated with SIRT3 reduction and mitochondrial dysfunction in proximal tubuli. SIRT3-deficient mice are more susceptible to AKI and die. Pharmacological manipulations able to increase SIRT3 preserve mitochondrial integrity, markedly limit renal injury, and accelerate functional recovery. This review highlights all the selective rescue mechanisms that point to the key role of SIRT3 as a new therapeutic target for curing renal diseases.

AB - Mitochondria are dynamic organelles whose functions are tightly regulated at multiple levels to maintain proper cellular homeostasis. Mitochondrial Sirtuin 3 (SIRT3), which belongs to an evolutionary conserved family of NAD+-dependent deacetylases, is a key regulator of the mitochondrial respiratory chain, ATP production, and fatty acid β-oxidation, and it exerts an antioxidant activity. Changes in SIRT3 expression are critical in the pathophysiology of several diseases, such as metabolic syndrome, diabetes, cancer, and aging. In experimental acute kidney injury (AKI), impairment of renal function and development of tubular injury are associated with SIRT3 reduction and mitochondrial dysfunction in proximal tubuli. SIRT3-deficient mice are more susceptible to AKI and die. Pharmacological manipulations able to increase SIRT3 preserve mitochondrial integrity, markedly limit renal injury, and accelerate functional recovery. This review highlights all the selective rescue mechanisms that point to the key role of SIRT3 as a new therapeutic target for curing renal diseases.

KW - Mitochondria

KW - Renal diseases

KW - Sirtuin 3

UR - http://www.scopus.com/inward/record.url?scp=84978044209&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84978044209&partnerID=8YFLogxK

U2 - 10.1159/000444370

DO - 10.1159/000444370

M3 - Article

JO - Experimental Nephrology

JF - Experimental Nephrology

SN - 0028-2766

ER -